Susan Searle

Bio

Joined Innovations in 1994, initially as Commercial Director and was appointed Chief Executive in January 2002. Innovations, which is quoted on the London Stock Market, has developed a proven business model that creates, builds and invests in pioneering technologies addressing global problems in healthcare, energy and engineering. It has built a portfolio of innovative companies with potential to generate significant returns for both investors and IP originators when technologies are commercialised in large multi-billion markets. Was previously employed at Montech (Australia), Signet Group, Bank of Nova Scotia and Shell Chemicals in the UK and internationally, in a variety of commercial roles. On the Board of several companies in which Innovations has invested including i2india, Evo Electric and Plaxica. MA in Chemistry from Exeter College, Oxford University.